Risk assessment of the diabetic foot and wound

International Wound Journal

Volumn 2, Issue 1, 2005, Pages 17-24

  Wu, Stephanie ^a   Armstrong, David G ^b  

^a Rosalind Franklin University of Medicine and Science Dr William M Scholl College of Podiatric Medicine   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Diabetic foot; Pressure; Risk assessment; Ulcer; Wound

Indexed keywords

ARTICLE; CUMULATIVE TRAUMA DISORDER; DIABETIC FOOT; DIABETIC NEUROPATHY; FOOT MALFORMATION; FOOT ULCER; HISTORY OF MEDICINE; HUMAN; LEG ISCHEMIA; METABOLIC REGULATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STRESS; WOUND COMPLICATION; WOUND INFECTION;

EID: 28244468415     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-4801.2005.00085.x     Document Type: Article

References (63)

1. Lavery LA, Ashry HR, van Houtum W, Pugh JA, Harkless LB, Basu S. Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care 1996;19(1):48-52.
2. Armstrong DG, Lavery LA, Quebedeaux TL, Walker SC. Surgical morbidity and the risk of amputation following infected puncture wounds of the foot in diabetic and non-diabetic adults. South Med J 1997;90(4):384-9.
3. Lavery LA, Armstrong DG, Wunderlich RP, Boulton AJM, Tredwell JL. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in mexican americans and non-hispanic whites from a diabetes disease management cohort. Diabetes Care 2003;26:1435-8.
4. Armstrong DG, Lipsky BA. Advances in the treatment of diabetic foot infections. Diabetes Technol Ther 2004;6:167-77.
5. Gibbons G, Eliopoulos GM. infection of the diabetic foot, in: Kozak GP, Hoar CS, Rowbotham, JL, editors. Management of Diabetic Foot Problems. Philadelphia: W.B. Saunders 1984:97-102.
6. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990;13:513-21.
7. Levin M. Pathophysiology of diabetic foot lesions. In: Davidson JK, editors. Clinical Diabetes Mellitus: A Problem-Oriented Approach. New York: Theime Medical, 1991:504-10.
8. Edelson GW, Armstrong DG, Lavery LA, Caicco G. The acutely infected diabetic foot is not adequately evaluated in an inpatient setting. Arch Intern Med 1996;156:2373-6.
9. National Diabetes Advisory Board. The National Long-Range Plan to Combat Diabetes. Bethesda: National. Institutions of Health, 1987:88-1587.
10. Edmonds ME. Experience in a multidisciplinary diabetic foot clinic. In: Connor H, Boulton AJM, Ward JD, editors. The Foot in Diabetes. Chichester: John Wiley and Sons, 1987:121-31.
11. Lavery LA, van Houtum WH, Armstrong DG. Institutionalization following diabetes-related lower extremity amputation. Am J Med 1997; 103(5):383-8.
12. Wylie-Rosset J, Walker EA, Shamoon H, Engel S, Basch C, Zybert P. Assessment of documented foot examinations for patients with diabetes in inner-city primary care clinics. Arch Fam Med 1990;4:46-50.
13. Cohen SJ. Potential barriers to diabetes care. Diabetes Care 1983;6:499-500.
14. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998;158:158-62.
15. Reiber GE, Vileikyte L, Boyko EJ, del Aguila M, Smith DG, Lavery LA, Boulton AJ. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22(1):157-62.
16. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999;22(7): 1036-42.
17. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Heagerty PJ. Prediction of diabetic foot ulcer using readily available clinical information: the Seattle Diabetic Foot Study. Diabetes 2002;51(2 Suppl):A18.
18. Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot, in: Bowker JH, Pfeifer MA, editors. The Diabetic Foot. St Louis: Mosby, 2001:13-32.
19. Birke JA, Sims DS. Plantar sensory threshold in the ulcerated foot. Lepr Rev 1986;57:261-7.
20. Armstrong DG, Abu Rumman PL, Nixon BP, Boulton AJM. Continuous activity monitoring in persons at high risk for diabetes-related lower extremity amputation. J Am Podiatr Med Assoc 2001;91:451-5.
21. Armstrong DG, Boulton AJM. Activity monitors: Should we begin dosing activity as we dose a drug? J Am Podiatr Med Assoc 2001;91:152-3.
22. Armstrong DG, Lavery LA, Kimbriel HR, Nixon BP, Boulton AJ. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care 2003;26(9): 2595-7.
23. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med 1998;158:289-92.
24. Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care 2000;23(7):984-8.
25. Armstrong DG. The 10-g monofilament: the diagnostic divining rod for the diabetic foot? [editorial] [in process citation]. Diabetes Care 2000; 23(7):887.
26. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. Jama 2005;293(2):217-8.
27. Armstrong DG, Lavery LA. Plantar pressures are higher in diabetic patients following partial foot amputation. Ostomy Wound Manage 1998;44(3): 30-2, 34, 36 passim.
28. Helm PA, Walker SC, Pulliam GF. Recurrence of neuropathic ulcerations following healing in a total contact cast. Arch Phys Med Rehabil 1991;72(12): 967-70.
29. Uccioli L, Faglia E, Monticone G, Favales F, Durola L, Aldeghi A, Quarantiello A, Calia P, Menzinger G. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995;18(10):1376-8.
30. Quebedeaux TL, Lavery LA, Lavery DC. The development of foot deformity and ulcers after great toe amputation in diabetes. Diabetes Care 1996;19(2):165-7.
31. Brand PW. The insensitive foot (including leprosy). In: Jahss M, editors. Disorders of the Foot and Ankle, 2nd edition. Philadelphia: Saunders, 1991: 2170-5.
32. Fernando DJ, Masson EA, Veves A, Boulton AJ. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1991;14(1):8-11.
33. Grant WP, Sullivan R, Soenshine DE, Adam M, Slusser JH, Carson KA, Vinik AI. Electron microscopic investigation of the effects of diabetes mellitus on the achilles tendon. J Foot Ankle Surg 1997;36(4):272-8.
34. Rosenbloom AL, Silverstein JH, Lezotte DC, Riley WJ, Maclaren NK. Limited joint mobility in diabetes mellitus of childhood: natural history and relationship to growth impairment. J Pediatr 1982; 101(5):874-8.
35. Rosenbloom AL. Skeletal and joint manifestations of childhood diabetes. Pediatr Clin North Am 1984; 31:569-89.
36. Armstrong DG, Lavery LA, Bushman TR. Peak foot pressures influence healing time of diabetic ulcers treated with total contact casting. J Rehabil Res Dev 1998;35:1-5.
37. Armstrong DG, Lavery LA. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg Am 1998;80(3):365-9.
38. Armstrong DG, Todd WF, Lavery LA, Harkless LB. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med 1997;14:357-63.
39. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes O. Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the oslo study. Br Med J 1986;293:1195-9.
40. Reeves WG, Wilson RM. infection, immunity, and diabetes. In: Alberti MM, DeFronzo RA, Kleen H, Zimmet P, editors. International Textbook of Diabetes Mellitus, 1st edition. West Sussex: John Wiley and Sons, 1992.
41. Larkin LG, Frier BM, Ireland JT. Diabetes mellitus and infection. Postgrad Med J 1985;61:233-7.
42. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992;15:1835-43.
43. Moss SE, Klein R, Klein BEK. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med 1992;152:610-6.
44. Maluf KS, Mueller MJ. Novel Award 2002. Comparison of physical activity and cumulative plantar tissue stress among subjects with and without diabetes mellitus and a history of recurrent plantar ulcers. Clin Biomech (Bristol, Avon) 2003;18(7):567-75.
45. Peters EJ, Lavery LA. Effectiveness of the diabetic foot risk classification system of the international working group on the diabetic foot. Diabetes Care 2001;24(8):1442-7.
46. Armstrong DG. The University of Texas Diabetic Foot Classification System. Ostomy Wound Manage 1996;42(8):60-1.
47. Armstrong DG, Peters EJ. Classification of wounds diabetic foot. Curr Diab Rep 2001;1:233-8.
48. Jeffcoate WJ, Macfarlane RM, Fletcher EM. The description and classification of diabetic foot lesions. Diabet Med 1993;10:676-9.
49. Arlt B, Protze J. Diabetic foot. Langenbecks Arch Chir Suppl Kongressbd 1997;114:528-32.
50. Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981;2:64-122.
51. Meggitt B. Surgical management of the diabetic foot. Br J Hosp Med 1976;16:227-332.
52. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation [see comments]. Diabetes Care 1998;21(5):855-9.
53. Grayson ML, Balaugh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273(9):721-3.
54. International Working Group on the Diabetic Foot, international Consensus on the diabetic foot. Maastricht: international Working Group on the Diabetic Foot, 1999.
55. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph NS, Karchmer AW, Le Frock JL, Lew DP, Mader JT, Norden C, Tan JS. Diagnosis and treatment of diabetic foot infections. Clin infect Dis 2004;39:885-910.
56. Edelman D, Hough DM, Glazebrook KN, Oddone EZ. Prognostic value of the clinical examination of the diabetic foot ulcer. J Gen intern Med 1997; 12(9)537-43.
57. Lavery LA, Armstrong DG, Quebedeaux TL, Walker SC. Puncture wounds: the frequency of normal laboratory values in the face of severe foot infections of the foot in diabetic and non-diabetic adults. Am J Med 1996;101:521-5.
58. Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg 1996;35(4):280-3.
59. Armstrong DG, Perales TA, Murff RT, Edelson GW, Welchon JG. Value of white blood cell count with differential in the acute diabetic foot infection. J Am Podiatr Med Assoc 1996;86(5):224-7.
60. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003;26(12):3333-41.
61. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004;109(6):733-9.
62. Hirsch AT, Gloviczki P, Drooz A, Lovell M, Creager MA. Special communication: mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health. Angiology 2004;55(3):233-42.
63. Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJM, Harkless LB. Offloading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001;24:1019-22.